Susie Harborth co-founded BioInnovation LLC with Peter Parker in 2009, and from 2010-2014 she was also Chief Financial Officer at GnuBIO Inc, a spin-out from Harvard University recently acquired by Bio-Rad Laboratories (NYSE:BIO). At GnuBIO, Susie led finance & operations and was responsible for strategy, HR, facilities and investor relations. Prior to joining GnuBIO, Susie was Vice President, Business Operations at Cequent Pharmaceuticals (acquired by Marina Biotech) where she was responsible for financial management, human resources, IT, facilities, legal, vendor and investor relations. She developed the initial business infrastructure for Boston Heart Diagnostics (BHDx) and provides operational support to a variety of start-ups including companies in molecular diagnostics, healthcare IT, SaaS, consumer and financial services industries.
Prior to Cequent, Susie focused on public life science companies at Leerink Partners LLC, where she was responsible for operations of the institutional sales trading department. In addition to her operational roles, Susie has held various financial, marketing, and administrative positions with Harmony Software (merged with Vigilance, Inc), Crimson Ventures and Alar Staffing Corp. She received her masters in biology (ALM) from Harvard University and an undergraduate degree in business administration/finance from California State University, Long Beach. Her graduate research was conducted at Massachusetts General Hospital (MGH) in the field of breast cancer diagnostics using HRMAS spectroscopy.